Anakinra

Anakinra (Kineret) - Pharmacist Review - Uses, Dosing, Side Effects

Anakinra (Kineret)

#anakinra | Uses, Dosage, Side Effects & Mechanism | Kineret

Anakinra (Kineret®): Evidence-Based Health Information Related to COVID-19

The Society of Infectious Diseases Pharmacists

QD 61 - When to Use Anakinra

QD27 - When to Stop Anakinra

KAWAKINRA Study - Anakinra in IVIG Refractory Kawasaki Disease

Pilot study of prophylactic anakinra to mitigate CAR-T-related neurotoxicity in R/R LBCL

VJHemOnc – Video Journal of Hematology & HemOnc

Anakinra in Pediatric, Adult Still's Disease: Dr. Bella Mehta

WORLD Symposium highlights Anakinra early results; upcoming gene therapy trial; + more

Cure Sanfilippo Foundation

ESC 23: ARAMIS: Anakinra versus Placebo in Acute Myocarditis

Radcliffe Cardiology

Len Walt of SOBI Talks Still's Disease and Anakinra

Rare Disease Report

The Science Behind Anakinra - Understanding its Mechanism of Action for Effective Treatment

Delivering Two Shots of Kineret With Only One Injection

Anakinra

How to Inject Kineret® (anakinra) for Adults

Chan Zuckerberg, Sanfilippo biomarkers & FDA; Anakinra trial update; + more

Cure Sanfilippo Foundation

QD202 -1st Line Anakinra (abstract #L12)

Anakinra prophylaxis in pts with RRMM receiving orvacabtagene autoleucel (orva-cel)

International Myeloma Foundation

Clinical Trial of Anakinra (Interleukin 1 Receptor Antagonist) in MAS - Randy Cron